Legal entity

Corcept Therapeutics Incorporated

Company CORT

All 1 tracked stories fall under one category: corporate-law. Nasdaq is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 10 original sources on average, compared with 2.7 for the broader beat in this window.

Last mentioned: Feb 24, 2026

Entity pulse

Recent coverage · Corcept Therapeutics Incorporated

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Corcept Therapeutics Incorporated

All 1 tracked stories fall under one category: corporate-law. Nasdaq is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 10 original sources on average, compared with 2.7 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 6.3 for that window. We currently track 1 Legal story that mention Corcept Therapeutics Incorporated, all published on February 24, 2026.

Stories tracked
1
Sources per story
10

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 50 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Corcept Therapeutics Incorporated. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Corcept Therapeutics Incorporated 1

Corporate Law Neutral

Corcept Therapeutics Faces Securities Fraud Suit Over Disclosure Failures

Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.

10 sources

Source: Finger Lakes Times · Pr Newswire

Corcept Therapeutics Incorporated is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.